Person profile
Public information reviewedLorena Lerner
Operating / professional title
Chief Scientific Officer at Keros Therapeutics, Inc. (NASDAQ: KROS)
Keros Therapeutics, Inc. (NASDAQ: KROS)
Chief Scientific Officer · Current mandate
C Suite · Us Listed
- Public sources
- 1 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- Sep 6, 2026
Alpha Registry